Interferon tau-induced hepatocyte apoptosis in sheep

Area of Science:

• Hepatology
• Immunology
• Molecular Biology

Background:

• Clinical use of Type I interferons (IFNs) is hindered by adverse effects.
• Mechanisms underlying Type I IFN-induced hepatotoxicity remain largely unknown.

Purpose of the Study:

• To investigate the mechanisms of acute hepatic injury induced by systemic administration of Type I IFN-tau in lambs.
• To elucidate the role of apoptosis and cell cycle regulation in IFN-tau-mediated liver damage.

Main Methods:

• Systemic administration of IFN-tau or saline to lambs.
• Histopathological examination of liver tissues at 24, 48, and 96 hours post-treatment.
• Biochemical analysis of aspartate transaminase (AST) levels.
• Immunohistochemistry for proliferating cell nuclear antigen (PCNA).
• Northern blot analysis and Western blotting for bax-alpha and bcl-2 expression.
• Mitochondrial bax-alpha level assessment.

Main Results:

• IFN-tau induced acute hepatopathy, characterized by cellular swelling, cytoplasmic aggregates, and hepatocyte apoptosis.
• Elevated AST levels and a significant increase in apoptotic hepatocytes were observed in IFN-tau treated lambs.
• IFN-tau caused hepatocyte growth arrest at the G0/G1 phase, with hepatocytes in S or G2 phase eliminated by apoptosis.
• Increased expression of the pro-apoptotic molecule bax-alpha mRNA and protein, including mitochondrial localization, was noted.
• No significant change in the anti-apoptotic molecule bcl-2 expression was detected.

Conclusions:

• IFN-tau induces hepatocyte apoptosis and growth arrest, potentially via regulation of bax-alpha expression.
• These findings elucidate key mechanisms of Type I IFN-induced hepatotoxicity relevant to both veterinary and human medicine.